Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) as a Bridge to Transplant in Unresectable Hepatocellular Carcinoma
Ann Surg Oncol
.
2022 Jan;29(1):33-34.
doi: 10.1245/s10434-021-10278-6.
Epub 2021 Jun 11.
Authors
Emily A Verbus
1
,
Alexander J Rossi
1
,
Martha Teke
1
,
Francis W Nugent
2
,
Jonathan M Hernandez
3
4
Affiliations
1
Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
2
Department of Oncology, Lahey Clinic, Burlington, MA, USA. francis.w.nugent@lahey.org.
3
Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. jonathan.hernandez@nih.gov.
4
Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. jonathan.hernandez@nih.gov.
PMID:
34117572
DOI:
10.1245/s10434-021-10278-6
No abstract available
Publication types
Letter
MeSH terms
Carcinoma, Hepatocellular* / therapy
Chemoembolization, Therapeutic*
Humans
Liver Neoplasms* / therapy
Propensity Score
Radiosurgery*
Retrospective Studies
Treatment Outcome